Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multilayer Biological Analysis of Novel Monoclonal Antibodies (MABs) in B-Cell Non-Hodgkin Lymphoma (NHL): A Translational and Prospective Observational Study Within Italian Clinical Practice (BIO-FIL_MAB Trial)

NCT07767799 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT07767799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07767799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multilayer Biological Analysis of Novel Monoclonal Antibodies (MABs) in B-Cell Non-Hodgkin Lymphoma (NHL): A Translational and Prospective Observational Study Within Italian Clinical Practice (BIO-FIL_MAB Trial)
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
October 31, 2041
Enrollment
1,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell non-hodgkin lymphoma (nhl)